671 related articles for article (PubMed ID: 27581198)
1. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
Lindahl A; Forshed J; Nordström A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
3. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
[TBL] [Abstract][Full Text] [Related]
4. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Li Y; Song X; Zhao X; Zou L; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity.
Ning P; Zheng Y; Luo Q; Liu X; Kang Y; Zhang Y; Zhang R; Xu Y; Yang D; Xi W; Wang K; Chen Y; An S; Gao Z
Crit Care; 2018 May; 22(1):130. PubMed ID: 29759075
[TBL] [Abstract][Full Text] [Related]
6. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
Peng J; Chen YT; Chen CL; Li L
Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
[TBL] [Abstract][Full Text] [Related]
7. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
8. LC/MS-based polar metabolite profiling reveals gender differences in serum from patients with myocardial infarction.
Lee J; Jung Y; Park JY; Lee SH; Ryu DH; Hwang GS
J Pharm Biomed Anal; 2015 Nov; 115():475-86. PubMed ID: 26299524
[TBL] [Abstract][Full Text] [Related]
9. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Qi Y; Song Y; Gu H; Fan G; Chai Y
Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis.
Chen DY; Chen YM; Chien HJ; Lin CC; Hsieh CW; Chen HH; Hung WT; Lai CC
PLoS One; 2016; 11(12):e0168147. PubMed ID: 28005947
[TBL] [Abstract][Full Text] [Related]
11. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors.
Liu Z; Yin P; Amathieu R; Savarin P; Xu G
Anal Bioanal Chem; 2016 Nov; 408(27):7641-7649. PubMed ID: 27614981
[TBL] [Abstract][Full Text] [Related]
12. Metabolite variations between acute-on-chronic liver failure and chronic liver failure caused by hepatitis B virus based on ultra-performance liquid chromatography mass spectrometry.
Lian J; Li X; Wang Y; Yang J; Liu W; Ma J; Chen D; Li L; Huang J
Biomed Pharmacother; 2016 Dec; 84():994-1000. PubMed ID: 27768929
[TBL] [Abstract][Full Text] [Related]
13. Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling.
Tebani A; Schmitz-Afonso I; Abily-Donval L; Héron B; Piraud M; Ausseil J; Brassier A; De Lonlay P; Zerimech F; Vaz FM; Gonzalez BJ; Marret S; Afonso C; Bekri S
Clin Chim Acta; 2017 Dec; 475():7-14. PubMed ID: 28982054
[TBL] [Abstract][Full Text] [Related]
14. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis.
Li J; Che N; Xu L; Zhang Q; Wang Q; Tan W; Zhang M
Clin Rheumatol; 2018 Jun; 37(6):1493-1502. PubMed ID: 29442259
[TBL] [Abstract][Full Text] [Related]
15. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
Shen W; Han W; Li Y; Meng Z; Cai L; Li L
Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
[TBL] [Abstract][Full Text] [Related]
16. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program.
Zhang AH; Wang P; Sun H; Yan GL; Han Y; Wang XJ
Mol Biosyst; 2013 Sep; 9(9):2259-65. PubMed ID: 23821129
[TBL] [Abstract][Full Text] [Related]
17. Joint MS-based platforms for comprehensive comparison of rat plasma and serum metabolic profiling.
Lin Z; Zhang Z; Lu H; Jin Y; Yi L; Liang Y
Biomed Chromatogr; 2014 Sep; 28(9):1235-45. PubMed ID: 24619916
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of serum metabolites in gestational diabetes mellitus by UPLC/Q-TOF-MS.
Liu T; Li J; Xu F; Wang M; Ding S; Xu H; Dong F
Anal Bioanal Chem; 2016 Feb; 408(4):1125-35. PubMed ID: 26677023
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]